Ryzolt is the brand name for Tramadol. It is a non-narcotic pain reliever with a dual matrix delivery system administered for long term, around the clock pain management. As a central nervous system depressant or “downers”, as they are sometimes called, it reduces stimulation in the brain by lowering neurotransmission levels. The dual delivery properties of Ryzolt also means that the drug has two complementary mechanisms that are capable of both an immediate and a slow release activity.
Extended release Ryzolt tablets may be white or off white and contain formulations of 100 mg, 200 mg or 300 mg of Tramadol hydrochloride as the active ingredient. Inactive ingredients may include colloidal silicon dioxide, hydrogenated vegetable oil, magnesium stearate, polyvinyl acetate, povidone, and sodium lauryl sulfate and xantham gum. The onset of pain relief from an immediate-release Ryzolt tablet is expected to occur within an hour.
Ryzolt (Tramadol) was developed by a German Pharmaceutical company under the ownership of the Wirtz family in 1962. This drug underwent fifteen years of uninterrupted investigation by the mother company before it was launched for use by the medical community in 1977. Because of the drug’s dual molecular components, it quickly gained global popularity that revolutionized the painkiller market because it was different from other opioids. Today, the drug is produced by numerous drug companies under hundreds of brand names such as Ryzolt. This widespread production and use has resulted in evolutionary processes that has improved the drug’s characteristics over the last 20 years.
The combined efforts of the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) has categorized Ryzolt (Tramadol) as a Schedule IV Controlled substance. Under this classification, the drug has accepted medical use but also low potential for abuse that may result in limited physical or psychological dependence.
Extensive clinical research studies conducted on this drug show that most health risks associated with Ryzolt are treatable. However, as with all synthetic drugs, there is the potential for serious side effects to occur in some patients that may necessitate emergency medical care such as hallucinations, seizures and difficulty breathing.
Although Ryzolt is a non-narcotic medication, users have experienced abuse and addiction to this drug. Because the drug is typically used to treat chronic and acute pain from conditions such as rheumatoid arthritis, fibromyalgia and cancer, it is easily facilitates the gradual increase in dosage if tolerance levels begin to increase from habitual use of the drug. Also, the drug’s slow onset of relief may also contribute to abuse. According to the Centers for Disease Control, accidental overdose from tramadol and other opioid drugs has been steadily increasing. In some instances, those who died from an overdose of Ryzolt (Tramadol) were prescribed the medication to treat a legitimate medical condition.
Based on data from the National Institute on Drug Abuse, those addicted to drugs such as Ryzolt accounted for the largest number of drug-related admissions to treatment facilities which underscores the addictive nature of many Schedule IV drugs. Individuals who have developed a dependence and addiction to the drug are very often unaware of this fact because they have been using and need this prescribed medication to control chronic pain. Due to chronic abuse most Ryzolt users function below optimum levels on a regular basis. According to the Mayo Clinic, you may be addicted to Ryzolt if any of the following issues apply to you.
If the use of Ryzolt has become an addiction, professional help may be required to overcome this condition. There are various treatment options such as:
All drug rehab programs commence with a thorough physical and psychological evaluation which often highlight comorbid conditions that may be driving the addictive behavior. Dual diagnosis treatment is also available which occurs simultaneously with addiction remedial procedures including relapse prevention training in order to facilitate full recovery and the ability to prevent recurring relapse events.
If you or a loved one has a chronic illness that has led to the use and abuse of Ryzolt, we can help. Call our Drug Rehab Treatment Centers at 877-855-3470 today and speak to our compassionate and experienced addiction counselors about a treatment program that is right for you.